LeonaBio (LONA) Net Cash Flow Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -65.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.53% |
| Dec 31, 2025 | 268.12% |
| Sep 30, 2025 | 119.83% |
| Jun 30, 2025 | -254.96% |
| Mar 31, 2025 | -72.50% |
| Dec 31, 2024 | -45.78% |
| Sep 30, 2024 | -50.94% |
| Jun 30, 2024 | -49.89% |
| Mar 31, 2024 | -235.39% |
| Dec 31, 2023 | -316.39% |
| Sep 30, 2023 | 58.87% |
| Jun 30, 2023 | 137.12% |
| Mar 31, 2023 | 25.96% |
| Dec 31, 2022 | 184.42% |
| Sep 30, 2022 | 67.14% |
| Jun 30, 2022 | -686.75% |
| Mar 31, 2022 | -88.86% |
| Dec 31, 2021 | 103.05% |
| Sep 30, 2021 | -130.25% |
| Jun 30, 2021 | -95.30% |
| Mar 31, 2021 | 9,989.79% |
| Dec 31, 2020 | -46,819.64% |